APEC1621 Pediatric MATCH Study (Tumor Genetics) - Clinical Trial

If you choose to join this study, you will:
- Have tumor tissue from a biopsy sent to a lab for genetic testing
-- If the tumor tissue has a genetic change that is targeted by one or more of the study drugs being tested in this study, you may be assigned to that study.

Solid tumors, non-Hodgkin lymphomas, Sarcoma, CNS tumors

Children and adults with recurrent solid tumors, lymphoma, and CNS tumors who:
- Are 1-21 years of age
- Have no uncontrolled infection
- Have had a prior solid organ transplant

We are doing this study to see if different study drugs or drug combinations that target specific genetic changes found in some cancers will shrink the tumor and/or prolong the time to progression.